Subcutaneous immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue SUPPL. 82, 2006, Pages 5-13

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BEE VENOM; GLUCOCORTICOID; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; PLACEBO; WASP VENOM;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGY; ALTERNARIA; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATOPIC DERMATITIS; ATOPY; BIRCH; CAT; CLADOSPORIUM; CLINICAL TRIAL; CONJUNCTIVITIS; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ERYTHEMA; FOOD ALLERGY; FORCED EXPIRATORY VOLUME; GRASS; HUMAN; IMMUNOTHERAPY; LOCAL SKIN REACTION; LUNG FUNCTION; OLIVE; PARIETARIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RAGWEED; REVIEW; RHINITIS; RHINOCONJUNCTIVITIS; SKIN TEST; SNEEZING; SWELLING; URTICARIA;

EID: 33748566007     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01219_3.x     Document Type: Review

References (33)

1. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-472.
2. Bousquet J, Van Cauvenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:147-334.
3. Malling HJ, Weeke B. EAACI Immunotherapy position papers. Allergy 1993;48(Suppl. 14):9-35.
4. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brian F, Noble W et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475.
5. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. Br Med J 1991;302:265-269.
6. Bousquet J, Lockey RF, Malling H-J (Eds). WHO Position Paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl 44):1-42.
7. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus product. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
8. Tabar AI, Garcia BE, Rodriguez A, Olaguibel JM, Muro MD, Quirce S. A prospective safety-monitoring study of immunotherapy with biologically standardized products. Allergy 1993;48:450-453.
9. Wells JH. Systemic reactions to immunotherapy: comparisons between two large allergy practices. J Allergy Clin Immunol 1996;97:1030-1032.
10. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U. EAACI Interest Group on Insect Venom Hypersensitivity Group. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:1459-1470.
11. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial in insect hypersensitivity. New Engl J Med 1978;299:157-161.
12. Müller U, Thurnheer U, Patrizzi R, Spiess J, Hoigné R. Immunotherapy in bee sting hypersensitivity: bee venom versus whole body product. Allergy 1979;34:369-378.
13. Brown S, Wiese M, Blackman K, Heddle R. Ant venom immunotherapy: a double blind, placebo controlled cross-over trial. Lancet 2003;361:1001-1006.
14. Rueff F, Przybilla B, Müller U, Mosbech H. The sting challenge test in hymenoptera venom allergy. Allergy 1996;51:216-225.
15. Müller U, Helbling A, Berchtold E. Immunotherapy with honey bee venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992;89:529-535.
16. Mosbech H, Müller U. Side effects of insect venom immunotherapy: results from an EAACI multicenter study. Allergy 2000;55:1005-1010.
17. Müller U, Mosbech H. EAACI Position Paper: immunotherapy with Hymenoptera venoms. Allergy 1993;48:36-46.
18. Müller U, Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 2005;115:606-610.
19. Des Roches A, Paradis L, Ménardo J-L, Bouges S, Daurès J-P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus product. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450-453.
20. Purello-D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Purcinelli P, Parmiciani S et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or nor. A retrospective study. Clin Exp Allergy 2001;31:1295-1302.
21. Pajno GB, Barberio G, de Luca FR, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-1397.
22. Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-256.
23. Valenta R, Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Current Opinion in Immunology 2002;14:718-727.
24. Adkinson NF Jr., Eggleston PA, Eney D, Goldstein EO, Schuberth KC, Bacon JR et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997;336:324-331.
25. Malling H-J. Minimising the risks of allergen-specific injection immunotherapy. Drug Saf 2000;23:323-332.
26. Javeed N, Javeed H, Javeed S, Moussa G, Wong P, Rezai F. Refractory anaphylactoid shock potentiated by β-blockers. Cathet Cardiovasc Diagn 1996;39:383-384.
27. Wantke F, Demmer CM, Götz M, Jarisch R. Inhibition of diamine oxidase is a risk in specific immunotherapy. Allergy 1993;48:552.
28. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus product. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
29. Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96:971-979.
30. Nielsen L, Johnsen ER, Mosbech H, Poulse LK, Malling H-J. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;97:1207-1213.
31. Müller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-86.
32. Delacourt C, Benoist MR, Wearnessyckle S, Rufin P, Brouard JJ, de Blic J et al. Relationship between bronchial responsiveness and clinical evolution in infants who wheeze: a fouryear prospective study. Am J Respir Crit Care Med 2001;164:1382-1386.
33. van den Toorn LM, Overbeek SE, Prins JB, Hoogsteden HC, de Jongste JC. Asthma remission: does it exist? Curr Opin Pulm Med 2003;9:5-20.